Advertisement

Pharmacy World and Science

, Volume 21, Issue 1, pp 35–39 | Cite as

An accelerated stability study of 5‐flucytosine in intravenous solution

  • Andras Vermes
  • Heleen van der Sijs
  • Henk‐jan Guchelaar
Article

Abstract

The stability of the antimycotic drug flucytosine (5‐FC) and the extent of 5‐fluorouracil (5‐FU) formation in 5‐FC intravenous solution was studied in an accelerated stability experiment. 5‐FC intravenous solution (10 mg/ml) was heated at 40, 60, 70, 80 and 90 ∘C for a maximum of 131 days. At appropriate time intervals samples were taken and the concentrations of 5‐FC and 5‐FU were determined using a newly developed, stability indicating HPLC‐UV method. Heating the 5‐FC intravenous solution at 40, 60, 70, 80 and 90 ∘C lead to 5‐FC decomposition of respectively 0, 8.9, 14.4, 52.5 and 61.6%. The Arrhenius plot of the 5‐FC decomposition is described by: Lnk5-FC decomposition = 80.1892 * 1/T ‐ 0.2396 and the 5‐FU formation is described by Lnk5‐FU formation = ‐13087 * 1/T + 34.4028. It is concluded that 5‐FC is very stable in intravenous solution at regular storing temperatures and can therefore be stored at ambient temperatures for several years before the critical limit of 95% 5‐FC is reached. However, the toxic and teratogen degradation product 5‐FU may be present in considerable amounts in the product, due to both impurities in the raw material and the formation from 5‐FC upon sterilisation and storage.

Ancotil® intravenous solution Flucytosine 5‐Fluorouracil High‐performance liquid chromatography (HPLC) Accelerated stability study Drug stability 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anonymous. Productinformation Ancotil® intravenous solution. Mijdrecht, The Netherlands: Roche Nederland b.v. 1996.Google Scholar
  2. 2.
    Anonymous. Informatorium Medicamentorum. Alphen aan den Rijn: Drukkerij C. Haasbeek b.v., 1997.Google Scholar
  3. 3.
    Cavrini V, Bonazzi D, Di Pietra AM. Analysis of flucytosine dosage forms by derivative UV spectroscopy and liquid chromatography. J Pharm Biomed Anal 1991;9:401-7.PubMedGoogle Scholar
  4. 4.
    Allen LV Jr, Erickson MA. Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids. Am J Health-Syst Pharm 1996;53:1944-9.PubMedGoogle Scholar
  5. 5.
    Wintermeyer SM, Nahata MC. Stability of flucytosine in extemporaneously compounded oral liquid. Am J Health-Syst Pharm 1996;53:407-9.PubMedGoogle Scholar
  6. 6.
    Beijnen JH, Branje JPAH, van Niel JCC, Touw DJ. Protocol stabiliteitsonderzoek van geneesmiddelen in waterige oplossing. 's Gravenhage: Nederlandse Vereniging van Ziekenhuisapothekers, 1993.Google Scholar
  7. 7.
    Grimm W, Schepky G. Stabilitätsprüfung in der Pharmazie, Theorie und Praxis. Aulendorf: Editio Canter, 1980.Google Scholar
  8. 8.
    Milovanovic D, Nairn JG. Stability of fluorouracil in amber glass bottles (Letter). Am J Hosp Pharm 1980;41:164-5.Google Scholar
  9. 9.
    Stiles ML, Allen LV, Hu Y-H. Stability of fluorouracil administered through four portable infusion pumps. Am J Hosp Pharm 1986;46:2036-40.Google Scholar
  10. 10.
    Quebbeman EJ, Hamid AAR, Hoffman NE, Ausman RK. Stability of fluorouracil in plastic containers used for continuous infusion at home. Am J Hosp Pharm 1986;41:1153-6.Google Scholar
  11. 11.
    Rochard EB, Barthès DMC, Courtois PY. Stability of fluorouracil, cytarabine, or doxorubicin hydrochloride in ethylene vinylacetate portable infusion pumps. Am J Hosp Pharm 1992;49:619-23.PubMedGoogle Scholar
  12. 12.
    Martel P, Petit I, Pinguet F, Poujol S, Astre C, Fabbro M. Long-term stability of 5-fluorouracil stored in PVC bags and in ambulatory pump reservoirs. J Pharm Biomed Anal 1996;14:395-9.PubMedGoogle Scholar
  13. 13.
    Northcott M, Allsopp MA, Powell H, Sewell GJ. The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged 'in use' conditions. J Clin Pharm Ther 1991;16:123-9.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Andras Vermes
  • Heleen van der Sijs
  • Henk‐jan Guchelaar

There are no affiliations available

Personalised recommendations